Brief: Genocea Biosciences Reports Q2 Loss Per Share Of $0.39

Genocea Biosciences

23/07/2020 12:23

July 23 (Reuters) - Genocea Biosciences Inc  GNCA.O :
    * FILED IND APPLICATION FOR GEN-011 AND IS WORKING WITH FDA
TO
PROVIDE ADDITIONAL INFORMATION
    * UPCOMING GEN-009 DATA UPDATE PLANNED FOR JULY 30TH
    * GENOCEA BIOSCIENCES - EXPECTS EXISTING CASH, CASH
EQUIVALENTS
INCLUSIVE OF PRIVATE PLACEMENT PROCEEDS ARE SUFFICIENT TO
SUPPORT OPERATIONS TO MID-2022
    * AS OF JUNE 30, 2020, CASH AND CASH EQUIVALENTS WERE $22.1
MILLION VERSUS $40.1 MILLION AS OF DECEMBER 31, 2019
    * QTRLY LOSS PER SHARE $0.39
    * Q2 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6DLBq3 
Further company coverage:  GNCA.O 

 ((Reuters.Briefs@thomsonreuters.com;))